Literature DB >> 9292799

Multiple T cell expansions are found in the blood and synovial fluid of patients with reactive arthritis.

R L Allen1, G M Gillespie, F Hall, S Edmonds, M A Hall, B P Wordsworth, A J McMichael, P Bowness.   

Abstract

OBJECTIVE: To look for evidence of T lymphocyte expansions in the blood and synovial fluid (SF) of patients with reactive arthritis (ReA).
METHODS: Paired peripheral blood and synovial samples from 10 patients with ReA were studied by dual color flow cytometry using T cell receptor (TCR) V beta specific and CD4 or CD8 specific antibodies. Two synovial CD8 expansions were studied by 3 color flow cytometry. Peripheral blood samples from 13 healthy, age matched individuals were studied as controls.
RESULTS: Statistically significant expansions were observed in all patients, occurring in blood and SF CD4 and CD8 compartments, but were most common in the synovial CD8 compartment. Expansions studied in further detail displayed an activated "memory" phenotype. A synovial BV22S1/CD8 expansion was seen in 5/6 patients with sexually acquired ReA.
CONCLUSION: Multiple T lymphocyte expansions are found in both the blood and SF of patients with ReA. Expansions were most commonly found in the synovial CD8 compartment, where they appeared to express both activation and memory markers. This indicates that T lymphocytes (and in particular cytotoxic T cells) may play a pathogenic role in ReA. These findings are consistent with either an antigen or a superantigen driven response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292799

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 3.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis.

Authors:  L Laloux; M C Voisin; J Allain; N Martin; L Kerboull; X Chevalier; P Claudepierre
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  Low molecular weight proteins of outer membrane of Salmonella typhimurium are immunogenic in Salmonella induced reactive arthritis revealed by proteomics.

Authors:  R Singh; A K Shasany; A Aggarwal; S Sinha; B S Sisodia; S P S Khanuja; R Misra
Journal:  Clin Exp Immunol       Date:  2007-03-22       Impact factor: 4.330

6.  Oligoclonal T cell expansions in patients with Behçet's disease.

Authors:  H Direskeneli; E Eksioglu-Demiralp; A Kibaroglu; S Yavuz; T Ergun; T Akoglu
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 7.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 8.  T cell genetics and rheumatoid arthritis (RA)

Authors:  P Wordsworth
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 9.  Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?

Authors:  Shi Huan Tay; Joo Guan Yeo; Jing Yao Leong; Salvatore Albani; Thaschawee Arkachaisri
Journal:  Front Med (Lausanne)       Date:  2021-05-20

10.  Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.

Authors:  S Chaurasia; A K Shasany; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.